Atypical Multifocal Granular Cell Tumor with FLT3 Y842C Somatic Mutation: A case report and a review of the literature

Authors

DOI:

https://doi.org/10.62438/tunismed.v102i10.5172

Keywords:

Case Report, Endoscopy, Immunohistochemistry, Next-Generation Sequencing

Abstract

Introduction. Granular cell tumors (GCT) are predominantly benign neoplasms composed by cells with abundant eosinophilic granular cytoplasm. Although the majority of GCTs exhibit a benign clinical course, a minority display cytological atypia and may exhibit aggressive, cancer-like behavior. Definitive evidence of malignancy in GCTs is reliably established only through the presence of metastasis. Addi- tionally, a subset of GCTs demonstrates a high rate of recurrence, underscoring the need for better prog- nostic markers. Therefore, it is crucial to identify molecular markers associated with aggressive behavior in GCTs. Molecular analysis may be particularly beneficial in cases exhibiting cytological atypia to in- form clinical outcome prognostication and guide therapeutic strategies.

Observation. In this case report, a 45-year-old female with multiple gastrointestinal GCTs is pre- sented. The patient did not have any genetic syndromes commonly associated with GCT, such as neu- rofibromatosis type 1, Noonan syndrome or LEOPARD syndrome. The tumors not only demonstrated nuclear atypia, but also harbored a unique FLT3 Y842C somatic alteration identified by next-genera- tion sequencing. The patient remains asymptomatic and under endoscopic surveillance two years after diagnosis and complete resection of the neoplasms.

Conclusion. We presented an exceedingly rare case of multifocal atypical GCT in an adult without any previously known genetic syndrome. A tumoral FLT3 Y842C point mutation not previously reported in GCT was discovered. Although the precise significance of this finding is uncertain, FLT3 Y842C has been cataloged as likely pathogenic in ClinVar. This report underscores the potential predictive utility of next-generation sequencing in the characterization ....(abstract truncated at 250 words)

Downloads

Download data is not yet available.

Author Biographies

  • Alexandra Zara Rozalen, Mount Sinai West, Department of Pathology, 10019, New York, NY. Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

    Mount Sinai West, Department of Pathology, 10019, New York, NY, USA

    Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

  • Ruth Garcia, Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

    Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

  • Samir Husami, Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

    Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

  • Gustavo Marino, Washington DC VA Medical Center, Division of Gastroenterology, 20422, Washington DC, USA.

    Washington DC VA Medical Center, Division of Gastroenterology, 20422, Washington DC, USA.

  • Victor E Nava, Washington DC VA Medical Center, Department of Pathology, 20422, Washington. The George Washington University Hospital, Department of Pathology, 20037, Washington, DC, USA.

    Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

    The George Washington University Hospital, Department of Pathology, 20037, Washington, DC, USA

References

Nasser H, Ahmed Y, Szpunar SM, Kowalski PJ. Malignant granular cell tumor: a look

into the diagnostic criteria. Pathol Res Pract. 2011;207(3):164-8.

Stemm M, Suster D, Wakely PE, Jr., Suster S. Typical and Atypical Granular Cell Tumors

of Soft Tissue: A Clinicopathologic Study of 50 Patients. Am J Clin Pathol. 2017;148(2):161-6.

Movahed S, Amiri AJ, Kalkali AR. A case report of atypical granular cell tumor of bladder.

Int J Surg Case Rep. 2024;121:109980.

Warren SJ, Alomari AK. Utility of sequencing for ATP6AP1 and ATP6AP2 to distinguish between atypical granular cell tumor with junctional component and melanoma. J Cutan Pathol.

;50(11):1014-9.

Liu JP, Song LX, Xu ZY, Wu Y, Yao XC, Li M, et al. Case report: Giant atypical granular

cell tumor of the median nerve. Front Neurol. 2023;14:1221912.

Wei MZ, Yan ZJ, Jiang JH, Jia XL. Atypical granular cell tumor of the urinary bladder: A

case report. World J Clin Cases. 2021;9(28):8453-60.

Tufano A, Canale V, Di Lascio G, Coppola G, Flammia RS, Cristini C. Atypical granular

cell tumor of the urinary bladder: A case report and literature review. Urol Case Rep.

;38:101669.

Brunsgaard EK, Wallis L, Cody B, Cavanaugh K. Atypical granular cell tumor developing

within a tattoo. JAAD Case Rep. 2020;6(6):546-8.

Nakamura Y, Fujino T, Nagata K, Imamura T, Teramoto Y, Asami Y, et al. A Rare Case

of a Primary Cutaneous Desmoplastic Atypical Granular Cell Tumor. Am J Dermatopathol.

;39(4):e50-e3.

Oh KY, Kang KR, Yoon HJ, Lee JI, Hong SP, Hong SD. Atypical granular cell tumor in

the maxilla: The first report of primary intraosseous granular cell tumor. Head Neck.

;38(8):E2467-70.

Mahoney A, Garg A, Wolpowitz D, Mahalingam M. Atypical granular cell tumor-apropos

of a case with indeterminate malignant potential. Am J Dermatopathol. 2010;32(4):370-3.

Ayadi L, Khabir A, Fakhfakh I, Abdelmoula MH, Makni S, Sellami Boudawara T.

[Granular cell tumor]. Rev Stomatol Chir Maxillofac. 2008;109(3):158-62.

Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG. Malignant granular cell

tumor of soft tissue: diagnostic criteria and clinicopathologic correlation. Am J Surg Pathol.

;22(7):779-94.

Schrader KA, Nelson TN, De Luca A, Huntsman DG, McGillivray BC. Multiple granular

cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11.

Clin Genet. 2009;75(2):185-9.

Ramaswamy PV, Storm CA, Filiano JJ, Dinulos JG. Multiple granular cell tumors in a

child with Noonan syndrome. Pediatr Dermatol. 2010;27(2):209-11.

Pareja F, Brandes AH, Basili T, Selenica P, Geyer FC, Fan D, et al. Loss-of-function

mutations in ATP6AP1 and ATP6AP2 in granular cell tumors. Nat Commun. 2018;9(1):3533.

Wei L, Liu S, Conroy J, Wang J, Papanicolau-Sengos A, Glenn ST, et al. Whole-genome

sequencing of a malignant granular cell tumor with metabolic response to pazopanib. Cold

Spring Harb Mol Case Stud. 2015;1(1):a000380.

Kindler T, Breitenbuecher F, Kasper S, Estey E, Giles F, Feldman E, et al. Identification

of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute

myeloid leukemia (AML). Blood. 2005;105(1):335-40.

Cheng J, Qu L, Wang J, Cheng L, Wang Y. High expression of FLT3 is a risk factor in

leukemia. Mol Med Rep. 2018;17(2):2885-92.

AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017;7(8):818-31.

Additional Files

Published

2024-10-08